Start main page content

Clinical Trials

  • An Open-label, Uncontrolled, Multicentre Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy
  • An Open-Label, Multicentre Phase 2 Basket Study to Evaluate the Antitumor Activity and Safety of Lenvatinib in Children, Adolescents, and Young Adults with Relapsed or Refractory Solid Malignancies.
  • Single Dose Study Evaluating the Pharmacokinetics and Safety of Intravenous Polymyxin B in Hospitalised Neonates, Children and Adolescents: Global Antibiotic and Research Development Programme
Share